Rapid dual test for HIV and syphilis could save newborns in guatemala

NCT ID NCT07498153

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a rapid fingerstick test that checks for both HIV and syphilis at the same time in pregnant women visiting prenatal clinics in Guatemala. The goal was to see if this quick, on-the-spot screening would lead to more women being diagnosed and treated during pregnancy, ultimately preventing these infections from passing to their babies. The study enrolled 149 women and provided immediate treatment and ultrasound checks for those who tested positive.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Chembio HIV/Syphilis rapid POC test

What this could lead to

If successful, this screening approach could increase detection and treatment of syphilis and HIV in pregnant women, reducing infections passed to babies.

What could go wrong

This was a small, short-term study (149 participants over one week) in one location, so results may not apply broadly. The test's accuracy in real-world low-resource settings needs further validation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease sexually transmitted disease syphilis congenital syphilis prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University of Texas Health Science Center at Houston

    Houston, Texas, 77030, United States